Cohance Lifesciences Ltd., a pharmaceutical firm that provides development and manufacturing services to worldwide drug manufacturers, has named Mr. Yann D'Herve as CEO of its Contract Development and Manufacturing Organisation (CDMO) division. His appointment takes effect on August 1, 2025. 

The business announced the decision in an official statement, emphasising Mr. D'Herve's extensive experience in the pharmaceutical, healthcare, and speciality chemicals industries. His experience includes leadership positions in manufacturing, corporate strategy, and global commercial operations. 

Prior to joining Cohance, Mr. D'Herve was Senior Vice President and General Manager of Evonik's Healthcare division. In that job, he was in charge of over 2,600 personnel and nine manufacturing sites around the world. His responsibilities included complete financial and operational supervision over the company's CDMO segment. He previously worked as vice president of sales and services and held other executive positions at the same organisation. 

Mr. D'Herve has a master's degree in chemistry from CPE Lyon, France, and an MBA from the Université de Picardie Jules Verne, Amiens. 

Mr. Vivek Sharma, Executive Chairman of Cohance Lifesciences, welcomed the new CEO, saying, "We are delighted to welcome Yann to Cohance." "His extensive experience building complicated global pharmaceutical service organisations will be extremely valuable in advancing the expansion of our CDMO platform." 

In response to his hiring, Mr. D'Herve stated, "I am excited to join a growing CDMO with differentiated technologies such as ADCs and oligonucleotides and a strong global asset base." I am excited to collaborate with the Cohance team to help the development and manufacture of life-saving pharmaceuticals for our partners." 

CDMO services help pharmaceutical businesses develop and produce pharmaceuticals, from the research stage to full-scale manufacturing. Antibody drug conjugates (ADCs) are employed in targeted cancer therapy, whereas oligonucleotides are small DNA or RNA molecules used in genetic medicine.